Richard, I like these guys too, and feel strongly that their research stands a fair chance of filling -- or at least mitigating -- some huge unmet needs. And I have no doubts about the sincerity of Repligen's management. (I just wonder why a powerhouse like UofM didn't pursue its patent rights.)
> did not appreciate the way that they just quietly switched to autism and let angio slip away. <
Perhaps the tilt was not entirely objective.
I believe that Herlihy and his wife have two autistic daughters. If that's true -- and I'm pretty sure that it is -- I'm entirely sympathetic to his endeavor to make the best attempt to evaluate the possibilities of secretin.
If secretin helps a subset of autistic people, many families will get huge relief.
If he proves it to be a mere placebo, his credibility as a scientist/parent will speed an end to fruitless, expensive, and uncontrolled individual experiments that drain resources from other treatment options.
Curtis, Scott, and Rick,
Thanks for all the informative, interesting posts -- much more compelling than thinking about the current market, which will pass out of memory in reasonable time.
Curtis, thanks for the book tip. I'll be ordering it from the King County Library.
Best regards,
Cheryl |
